Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.230
+0.050 (2.29%)
At close: Dec 31, 2025, 4:00 PM EST
2.355
+0.125 (5.61%)
After-hours: Dec 31, 2025, 7:49 PM EST
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $8.14 million as of December 31, 2025. Its market cap has decreased by -61.22% in one year.
Market Cap
8.14M
Enterprise Value
3.35M
1-Year Change
-61.22%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $8.14M, a decrease of -95.09%. That is a compound annual growth rate of -24.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |